Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review

Date: July 30, 2014
Pages: 47
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: IEAFE0A0074EN
Leaflet:

Download PDF Leaflet

Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review
Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Interleukin Genetics, Inc. (Interleukin) develops and distributes genetic tests for the personalized health market. It offers its products and services under the brands, Inherent Health and PerioPredict. Inherent Health brand of genetic tests includes genetic tests in weight management, heart health, bone health, wellness select and nutritional needs. PerioPredict genetic test analyzes genetic variations that are associated with inflammation and helps in identifying individuals who are at increased risk for severe periodontal disease. Its genetic test product pipeline includes osteoarthritis genetic test for osteoarthritis (OA).

Interleukin Genetics, Inc. Key Recent Developments

May 14, 2014 Interleukin Genetics Reports First Quarter 2014 Financial Results
Mar 31, 2014 Interleukin Genetics Announces Changes to Its Board of Directors
Mar 20, 2014 Interleukin Genetics Reports Fourth Quarter and Year-End 2013 Financial Results
Mar 20, 2014 Interleukin Genetics reports fourth quarter and year-end 2013 financial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Interleukin Genetics, Inc. - Key Facts
Interleukin Genetics, Inc. - Key Employees
Interleukin Genetics, Inc. - Key Employee Biographies
Interleukin Genetics, Inc. - Major Products and Services
Interleukin Genetics, Inc. - Medical Equipment Pipeline Products Data
Interleukin Genetics, Inc. Pipeline Products by Equipment Type
Interleukin Genetics, Inc. Pipeline Products by Development Stage
Interleukin Genetics, Inc. - History
Interleukin Genetics, Inc. - Company Statement
Interleukin Genetics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Interleukin Genetics, Inc. - Business Description
Interleukin Genetics, Inc. - SWOT Analysis
SWOT Analysis - Overview
Interleukin Genetics, Inc. - Strengths
Strength - Focused Research and Development Activities
Strength - Strategic Collaborations
Strength - Patent Portfolio
Interleukin Genetics, Inc. - Weaknesses
Weakness - Dependence on Significant Customers
Weakness - History of Operating Losses
Interleukin Genetics, Inc. - Opportunities
Opportunity - New Product Launches and Strong Pipeline
Opportunity - Rising Healthcare Expenditure in the US
Opportunity - Growing IVD Market
Interleukin Genetics, Inc. - Threats
Threat - Competitive Landscape
Threat - Risk of Product Obsolescence
Threat - Stringent Government Regulations
Interleukin Genetics, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Interleukin Genetics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Interleukin Genetics, Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Interleukin Genetics, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 14, 2014: Interleukin Genetics Reports First Quarter 2014 Financial Results
Apr 11, 2014: Interleukin Genetics Publishes Additional Evidence for the PerioPredict Genetic Risk Test in Journal of Periodontal Research
Mar 31, 2014: Interleukin Genetics Announces Changes to Its Board of Directors
Mar 20, 2014: Interleukin Genetics Reports Fourth Quarter and Year-End 2013 Financial Results
Mar 20, 2014: Interleukin Genetics reports fourth quarter and year-end 2013 financial results
Nov 25, 2013: Interleukin Genetics Introduces PerioPredict
Nov 14, 2013: Interleukin Genetics Reports Third Quarter 2013 Financial Results
Nov 06, 2013: Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2013 Results
Aug 14, 2013: Interleukin Genetics Reports Second Quarter 2013 Financial Results
Aug 06, 2013: Interleukin Genetics Announces Conference Call to Discuss Second Quarter 2013 Results

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Interleukin Genetics, Inc., Key Facts
Interleukin Genetics, Inc., Key Employees
Interleukin Genetics, Inc., Key Employee Biographies
Interleukin Genetics, Inc., Major Products and Services
Interleukin Genetics, Inc. Number of Pipeline Products by Equipment Type
Interleukin Genetics, Inc. Pipeline Products by Equipment Type
Interleukin Genetics, Inc. Number of Pipeline Products by Development Stage
Interleukin Genetics, Inc. Pipeline Products by Development Stage
Interleukin Genetics, Inc., History
Interleukin Genetics, Inc., Subsidiaries
Interleukin Genetics, Inc., Key Competitors
Interleukin Genetics, Inc., Ratios based on current share price
Interleukin Genetics, Inc., Annual Ratios
Interleukin Genetics, Inc., Interim Ratios
Interleukin Genetics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Interleukin Genetics, Inc., Medical Equipment, Deals By Type, 2008 to YTD 2014
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Interleukin Genetics, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Interleukin Genetics, Inc. Pipeline Products by Equipment Type
Interleukin Genetics, Inc. Pipeline Products by Development Stage
Interleukin Genetics, Inc., Performance Chart (2009 - 2013)
Interleukin Genetics, Inc., Ratio Charts
Interleukin Genetics, Inc., Medical Equipment, Deals By Year, 2008 to YTD 2014
Interleukin Genetics, Inc., Medical Equipment, Deals by Type, 2008 to YTD 2014
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Interleukin Genetics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

Interleukin Genetics, Inc. (ILIU) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: